Efficient Intracellular Delivery of RNase A Using DNA Origami Carriers

ACS Appl Mater Interfaces. 2019 Mar 27;11(12):11112-11118. doi: 10.1021/acsami.8b21724. Epub 2019 Mar 19.

Abstract

Delivery of proteins to carry out desired biological functions is a direct approach for disease treatment. However, protein therapy is still facing challenges due to low delivery efficiency, poor targeting during trafficking, insufficient therapeutic efficacy, and possible toxicity induced by carriers. Here, we present a novel delivery platform based on DNA origami nanostructure that enables tumor cell transportation of active proteins for cancer therapy. In our design, cytotoxic protein ribonuclease (RNase) A molecules are organized on the rectangular DNA origami nanosheets, which work as nanovehicles to deliver RNase A molecules into the cytoplasm and execute their cell-killing function inside the tumor cells. Cancer cell-targeting aptamers are also integrated onto the DNA origami-based nanoplatform to enhance its targeting effect. This DNA origami-protein coassembling strategy can be further developed to transport other functional proteins and therapeutic components simultaneously for synergistic effects and be adapted for integrated diagnostics and therapeutics.

Keywords: DNA origami; RNase A; cancer therapy; protein delivery; self-assembly.

MeSH terms

  • Aptamers, Nucleotide / chemistry
  • Cell Line, Tumor
  • DNA / chemistry*
  • Drug Carriers / chemistry
  • Humans
  • Microscopy, Atomic Force
  • Mucin-1 / chemistry
  • Mucin-1 / metabolism
  • Nanostructures / chemistry
  • Ribonuclease, Pancreatic / chemistry
  • Ribonuclease, Pancreatic / metabolism*

Substances

  • Aptamers, Nucleotide
  • Drug Carriers
  • Mucin-1
  • DNA
  • Ribonuclease, Pancreatic